Shingrix in Renal Transplant Recipients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Shingrix in Renal Transplant Recipients — Stella

Recruiting

Back to Kidney Transplant Recipient Response to Shingrix Vaccine trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(4 sites)

United States

University of Colorado Anschutz, Aurora, Colorado

Emory University, Atlanta, Georgia

Brigham and Women's Hospital, Boston, Massachusetts

Baylor College of Medicine, Houston, Texas

Key details

Phase

Large-scale testing

Sponsor

University of Colorado, Denver

Collaborators

GlaxoSmithKline

Enrollment target

~132 participants

Started

March 2023

Primary completion

June 2029

Age range

18 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov